Publication | Closed Access

The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human

NanomedicinePharmaceutical ScienceEngineeringClinical Nanoparticle FormulationFood EffectPharmacological StudyPharmaceutical NanotechnologyBeagle Dog ModelNano-drug DeliveryBiomedical EngineeringPharmacologyBioavailability